CRO Future

Contract research organizations may have some brighter days ahead of them, says Ed Silverman at Pharmalot.

As pharmaceutical companies are showing signs of stability, Silverman says that'll rub off on CROs. He adds that during "the next several years, in fact, CROs sales are expected to grow in the mid-single digits."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.